DOCS vs VRTX
Doximity Inc (DOCS) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Doximity Inc (DOCS) is a health information services company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported DOCS revenue for 2025-03-31 was $570.4M. Net income was $223.2M. Revenue was up 20.0% from 2024-03-31 to 2025-03-31. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
DOCS currently screens at market cap $3.77B and trailing P/E 21.0. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the DOCS and VRTX stock pages for the full models.
Not investment advice.